Inside the research

CVS Health Corporation

CVS Research profile · latest available data

Price overview

$87.85

▼ -1.28 (-1.4%)

52w hi$109.92
52w lo$69.04
Vol7.90M
As of28 Sep 2026

The Verdict

Hold

Our score +0.08

Short-0.20
Medium+0.21
Long+0.37

computed 2026-09-28

Key fundamentals

CVS Health Corporation

Healthcare · Healthcare Plans

Market cap$112.36B
Enterprise value$176.54B
Trailing P/E23.18x
Forward P/E10.30x
EV / EBITDA10.58x
P / S (ttm)0.27x
Profit margin1.2%
Return on equity6.2%
Revenue growth+7.1%
Earnings growth+188.8%
Debt / equity95.50

Layer Breakdown

LayerRawContribution
Fundamental+0.28
Sector+0.09
Technical-0.09
Earnings+0.00
Sentiment-0.01

macro × 1.00 · 2026-09-28

Business overview

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

United States · www.cvshealth.com

Risk Metrics

Beta vs SPX0.30
Corr SPX0.14
Annual vol34.6%
Annual ret+27.1%
Sharpe0.78
Max DD-35.1%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$100.04
High / Low$140.00 / $79.00
Median$100.00
Analysts26
Strong Buy7
Buy18
Hold3
Sell0
Strong Sell0

Recent rating actions

2026-05-08Wells Fargo→ Overweight
2026-05-07UBS→ Buy
2026-05-07Truist Securities→ Buy
2026-05-07RBC Capital→ Outperform
2026-05-07Evercore ISI Group→ Outperform
2026-05-07Barclays→ Overweight

Officers & Board

CEODavid Joyner since 2024
DirectorKaren S. Lynch since 2021
DirectorRoger N. Farah since 2018
DirectorFernando Aguirre since 2018
DirectorEdward J. Ludwig since 2018
DirectorMary Lovelace Schapiro since 2017
DirectorAlecia A. DeCoudreaux since 2015
DirectorWilliam C. Weldon since 2013
DirectorNancy-Ann DeParle since 2013
CEOLarry Merlo since 2011
DirectorAnne Finucane since 2011
DirectorJean-Pierre Millon since 2007
DirectorC. David Brown II since 2007
DirectorMark T. Bertolini 2018–2020
DirectorRichard M. Bracken 2015–2020

Material Events

DateEvent8-K
2026-08-05Earnings Release, Exhibitsread
2026-05-18Officer / Director Change, Shareholder Voteread
2026-05-06Earnings Release, Exhibitsread
2026-03-19Officer / Director Changeread
2026-02-10Earnings Release, Exhibitsread
2025-12-09Reg FD Disclosure, Exhibitsread
2025-11-20Other Material Event, Exhibitsread
2025-10-29Earnings Release, Exhibitsread
2025-09-22Other Material Event, Exhibitsread
2025-08-15Other Material Event, Exhibitsread
2025-07-31Earnings Release, Exhibitsread
2025-05-20Shareholder Voteread

Insider Trades

DateInsiderRoleActionSharesValue
2026-06-26Clark James DavidSVP, Cont & Chief Acct OfWithheld for tax454$41.30K
2026-05-31Newman BrianEVP, Chief Financial OffiWithheld for tax2.48K$225.45K
2026-05-31Compton-Phillips AmyEVP, Chief Medical OfficeWithheld for tax7.62K$693.09K
2026-05-21AGUIRRE FERNANDODisposal1.56K$146.14K
2026-05-20AGUIRRE FERNANDODisposal30.44K$2.85M
2026-05-14AGUIRRE FERNANDOGrant1.56K$151.85K
2026-05-14Balser Jeffrey R.Grant2.06K$199.93K
2026-05-14KIRBY J SCOTTGrant1.45K$140.58K
2026-04-01Mandadi TilakEVP, Chief Exp & Tech OffWithheld for tax3.63K$263.43K
2026-04-01Nelson Steven HEVP and President, AetnaWithheld for tax2.43K$176.30K

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders9
Top-5 share97.1%
HHI3,646 (concentrated)

Top Holders

HolderValueShares
State Street Corp$6.24B60.28M
Fidelity / FMR LLC$2.99B28.92M
Citadel Advisors$1.06B10.29M
Capital Research / Capital World$796.46M7.70M
AQR Capital Management$248.94M2.41M
Millennium Management$246.47M2.38M
Renaissance Technologies$45.62M441.02K
Bridgewater Associates$45.62M440.97K
T. Rowe Price Group$2.50M24.20M

As of 2026-06-30

Connections

Subsidiarys: CVS Pharmacy

Customers: Care Benefits Pricing For Co

Dividends

Yield (TTM)2.27%
$ / share (TTM)$2.00
5y CAGR+5.9%

Annual dividend per share

2021$2.00
2022$2.20
2023$2.42
2024$2.66
2025$2.66
2026$1.33

Federal Contracts

AmountAgencyDescription
$16.80MDepartment of Health and Human ServicesBIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEI
$5.48MDepartment of Health and Human ServicesCENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EF
$1.73MDepartment of Health and Human ServicesBIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEI
$1.38MDepartment of Health and Human ServicesCENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EF
$498.15KDepartment of Health and Human ServicesCVS HEALTH CLINICAL TRIAL SERVICES LLC TO PROVIDE CLINICAL DECISION SUPPORT TO A
$26.60KDepartment of JusticePRICE BASED ON 3 TABS DAILY @ $161.52 PER TAB FOR 60DAYS
$19.98KEnvironmental Protection AgencyCOVID TESTING VOUCHERS WITH CVS
$14.52KDepartment of JusticeCVS HEALTH CORPORATION DBA CAREMARK LLC, (1) REMODULIN 5MG/ML VIAL, FY25

SEC Filings

DateFormDoc
2026-08-0613F-HRview
2026-08-0510-Qview
2026-08-058-Kview
2026-06-294view
2026-06-2311-Kview
2026-06-014view
2026-06-014view
2026-05-224view
2026-05-214view
2026-05-188-Kview
2026-05-154view
2026-05-154view
2026-05-154view
2026-05-154view
2026-05-154view

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$372.81B+8.7%
Gross profit$28.55B+7.4%
Operating income$8.52B+2.3%
Net income$8.34B+12.2%
Cash from ops$13.43B+7.8%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 28$89.51$90.01$87.84$87.857.90M
Sep 25$85.35$89.35$84.70$89.1315.77M
Sep 24$85.83$86.01$84.50$85.057.38M
Sep 23$86.70$86.98$85.67$85.867.31M
Sep 22$87.69$88.28$86.68$87.108.71M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →